Carta Healthcare secured $18.25M in Series B1 funding led by UPMC Enterprises with strategic health system investors to expand its AI-powered clinical data abstraction and analytics platform, accelerate growth especially in life sciences, and streamline data insights for care and research.
Investment led by UPMC Enterprises, with participation from MemorialCare Innovation Fund, Rex Health Ventures, Tampa General Hospital Ventures, Memorial Hermann Health System, Frist Cressey Ventures, Storm Ventures, Paramark Ventures, CU Healthcare Innovation Fund, and Mass General Brigham Ventures
The article stresses that better data sharing and collaboration speeds bench-to-bedside discoveries by streamlining clinical trial recruitment and data management using AI. Carta Healthcare’s AI clinical data platform helps accelerate research, extract real-world insights, and match patients to trials, supporting this collaborative translational effort.
At HIMSS25, AI’s practical use in healthcare was a central theme. Vendors, including Carta Healthcare, emphasized real-world AI applications that reduce admin burden, improve workflows, and support value-based care, showing where healthcare tech is moving beyond hype into measurable impact.
The article highlights AI’s role in improving patient outcomes and streamlining healthcare operations, including reducing admin burden and enhancing clinical decision support. Carta Healthcare’s AI clinical data tools fit this trend by improving data accuracy, speeding abstraction, and freeing clinicians for patient care.
HITConsultant highlights key HIMSS25 trends like AI, interoperability, and predictive analytics driving value-based care. Executives stressed the need for high-quality structured data for effective AI — aligning with Carta Healthcare’s AI clinical data abstraction platform that fuels better insights and workflows.
The article discusses whether AI can replace clinical data abstractors, noting Carta Healthcare’s survey showing most abstractors believe AI reduces workload but still needs human oversight for quality. Carta’s hybrid AI-plus-expert approach reflects this balance.
A Carta Healthcare survey found most clinical data abstractors believe AI can save time, reduce effort and cut costs, but many lack access to AI tools at work and worry about data quality without human oversight. Carta’s platform blends AI with expert review to address these gaps.
Carta Healthcare closed a $25M Series B funding round, including new investments from Memorial Hermann Health System and UnityPoint Health, building on an earlier $20M raise. The capital will help scale its clinical data tech that turns complex data into insights to improve patient care and efficiency.
The Becker’s piece shows health systems using generative AI and virtual nursing tools to reduce clinician burden—similar to how Carta Healthcare’s AI‑driven clinical data abstraction platform helps automate documentation and free care teams for higher‑value work.
Carta Healthcare raised $25 M in Series B funding with new investments from Memorial Hermann Health System and UnityPoint Health. The funding will support scaling its AI‑driven clinical data solutions to improve data abstraction, insights, and clinician efficiency across health systems.
The Forbes piece highlights huge administrative waste in healthcare from manual billing, coding, and documentation. Solutions like Carta Healthcare’s AI‑driven clinical data abstraction aim to cut this burden, reduce inefficiency, and free clinicians for more valuable patient care.
In 2022, major systems Mayo Clinic, Mass General Brigham, and Cedars‑Sinai made venture investments in health tech, including Mass General Brigham backing Carta Healthcare’s $20M Series B clinical data platform, showing how health systems are funding digital solutions to improve care and efficiency.
The article lists 17 digital health companies that collectively raised nearly $800M in recent deals. Among them, Carta Healthcare raised $20M in a funding round backed by health systems, highlighting investor interest in clinical data and AI solutions.
The Fierce Healthcare fundraising tracker lists recent digital health funding deals, including connectRN securing significant financing and virtual behavioral health firm Valera Health’s $44M raise, highlighting ongoing investment activity in health tech startups.
Carta Healthcare secured a $20M Series B funding round that included health systems like Mass General Brigham and UCHealth as investors. The AI-powered clinical data company will use the capital to scale its solutions that turn clinical data into actionable insights and reduce manual data burden for care teams.
Stay informed with the latest updates and expert insights. Explore breaking news and industry trends all in one place. Contact us for more!
2443 Fillmore St #380-17156 San Francisco, CA 94115
